Commonwealth Equity Services
AURA icon

Commonwealth Equity Services’s Aura Biosciences AURA Stock Holding History

Commonwealth Equity Services’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Buy
30,316
+32
+0.1% +$229 ﹤0.01% 4071
2026
Q1 		$203K Hold
30,284
– – ﹤0.01% 3997
2025
Q4 		$165K Sell
30,284
-568
-2% -$3.37K ﹤0.01% 4028
2025
Q3 		$191K Sell
30,852
-105
-0.3% -$687 ﹤0.01% 3959
2025
Q2 		$194K Buy
30,957
+679
+2% +$3.97K ﹤0.01% 3930
2025
Q1 		$177K Buy
30,278
+278
+0.9% +$2.1K ﹤0.01% 3871
2024
Q4 		$247K Hold
30,000
– – ﹤0.01% 3584
2024
Q3 		$267K Buy
30,000
+5,000
+20% +$42.9K ﹤0.01% 3452
2024
Q2 		$189K Buy
+25,000
New +$183K ﹤0.01% 3656

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Commonwealth Equity Services's AURA Position: Q2 2026 in Review

Commonwealth Equity Services increased its Aura Biosciences (AURA) stake by 0.11% in Q2 2026, buying an estimated $229 and bringing the position to 30,316 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #4071.

Commonwealth Equity Services first reported a position in AURA in Q2 2024 and has held it in 9 quarters since. The position peaked at $267K in Q3 2024. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Commonwealth Equity Services held 30,316 shares of Aura Biosciences worth $215K as of Q2 2026.
  • Commonwealth Equity Services bought 32 Aura Biosciences shares in Q2 2026, an estimated $229.
  • Aura Biosciences made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4071 holding.
  • Commonwealth Equity Services first reported a position in Aura Biosciences in Q2 2024 and has held it in 9 quarters since.
  • Commonwealth Equity Services's Aura Biosciences position peaked at $267K in Q3 2024.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.